BACKGROUND AND PURPOSE: Patients with extensive leukoaraiosis are at high risk for vascular dementia. However, these patients exhibit variable severity of global cognitive impairment correlating with callosal atrophy. We hypothesized that callosal atrophy may reflect the severity of HDWM tract damage, which may explain global cognitive impairment. The purpose of this study was to evaluate HDWM tract damage by DTI and to investigate whether HDWM tract damage is associated with callosal atrophy and global cognitive impairment, in patients with extensive leukoaraiosis. MATERIALS AND METHODS: Twenty-four consecutive outpatients with extensive leukoaraiosis were enrolled prospectively. The patients underwent cognitive evaluation and 3T MR imaging. The intercorrelation between cognitive score, DA of the HDWM, callosal DA, and callosal volume was analyzed statistically. The correlation of the cognitive score with DA of the HDWM and the corpus callosum was also evaluated by voxel-based analyses by using TBSS. RESULTS: The patients' MMSE scores varied from 10 to 30 (mean, 25.1 ± 6.0). Reduced DA of the HDWM, reduced callosal DA, and callosal atrophy intercorrelated significantly. All of these parameters showed a significant correlation with global cognitive impairment. TBSS analyses showed a significant correlation between MMSE score decline and reduced DA in the diffuse HDWM and the corpus callosum. CONCLUSIONS: In patients with extensive leukoaraiosis, atrophy and reduced DA of the corpus callosum may indicate diffuse HDWM tract damage, which may explain global cognitive impairment and development of vascular dementia.
BACKGROUND AND PURPOSE:Patients with extensive leukoaraiosis are at high risk for vascular dementia. However, these patients exhibit variable severity of global cognitive impairment correlating with callosal atrophy. We hypothesized that callosal atrophy may reflect the severity of HDWM tract damage, which may explain global cognitive impairment. The purpose of this study was to evaluate HDWM tract damage by DTI and to investigate whether HDWM tract damage is associated with callosal atrophy and global cognitive impairment, in patients with extensive leukoaraiosis. MATERIALS AND METHODS: Twenty-four consecutive outpatients with extensive leukoaraiosis were enrolled prospectively. The patients underwent cognitive evaluation and 3T MR imaging. The intercorrelation between cognitive score, DA of the HDWM, callosal DA, and callosal volume was analyzed statistically. The correlation of the cognitive score with DA of the HDWM and the corpus callosum was also evaluated by voxel-based analyses by using TBSS. RESULTS: The patients' MMSE scores varied from 10 to 30 (mean, 25.1 ± 6.0). Reduced DA of the HDWM, reduced callosal DA, and callosal atrophy intercorrelated significantly. All of these parameters showed a significant correlation with global cognitive impairment. TBSS analyses showed a significant correlation between MMSE score decline and reduced DA in the diffuse HDWM and the corpus callosum. CONCLUSIONS: In patients with extensive leukoaraiosis, atrophy and reduced DA of the corpus callosum may indicate diffuse HDWM tract damage, which may explain global cognitive impairment and development of vascular dementia.
Authors: Hanna Jokinen; Hely Kalska; Raija Ylikoski; Sofia Madureira; Ana Verdelho; Wiesje M van der Flier; Philip Scheltens; Frederik Barkhof; Marieke C Visser; Franz Fazekas; Reinhold Schmidt; John O'Brien; Gunhild Waldemar; Anders Wallin; Hugues Chabriat; Leonardo Pantoni; Domenico Inzitari; Timo Erkinjuntti Journal: Cerebrovasc Dis Date: 2009-03-10 Impact factor: 2.762
Authors: M O'Sullivan; R G Morris; B Huckstep; D K Jones; S C R Williams; H S Markus Journal: J Neurol Neurosurg Psychiatry Date: 2004-03 Impact factor: 10.154
Authors: R Della Nave; S Foresti; A Pratesi; A Ginestroni; M Inzitari; E Salvadori; M Giannelli; S Diciotti; D Inzitari; M Mascalchi Journal: AJNR Am J Neuroradiol Date: 2007-08 Impact factor: 3.825
Authors: Meike W Vernooij; M Arfan Ikram; Henri A Vrooman; Piotr A Wielopolski; Gabriel P Krestin; Albert Hofman; Wiro J Niessen; Aad Van der Lugt; Monique M B Breteler Journal: Arch Gen Psychiatry Date: 2009-05
Authors: Stephen M Smith; Mark Jenkinson; Heidi Johansen-Berg; Daniel Rueckert; Thomas E Nichols; Clare E Mackay; Kate E Watkins; Olga Ciccarelli; M Zaheer Cader; Paul M Matthews; Timothy E J Behrens Journal: Neuroimage Date: 2006-04-19 Impact factor: 6.556
Authors: W Reginold; J Itorralba; A C Luedke; J Fernandez-Ruiz; J Reginold; O Islam; A Garcia Journal: AJNR Am J Neuroradiol Date: 2016-04-28 Impact factor: 3.825
Authors: Y H W Tsui-Caldwell; T J Farrer; Z McDonnell; Z Christensen; C Finuf; E D Bigler; J T Tschanz; M C Norton; K A Welsh-Bohmer Journal: J Prev Alzheimers Dis Date: 2019
Authors: Eva M Quinque; Katrin Arélin; Juergen Dukart; Elisabeth Roggenhofer; Daniel-P Streitbuerger; Arno Villringer; Stefan Frisch; Karsten Mueller; Matthias L Schroeter Journal: J Cereb Blood Flow Metab Date: 2012-07-11 Impact factor: 6.200
Authors: William Reginold; Angela C Luedke; Angela Tam; Justine Itorralba; Juan Fernandez-Ruiz; Jennifer Reginold; Omar Islam; Angeles Garcia Journal: Dement Geriatr Cogn Dis Extra Date: 2015-10-21
Authors: Robert Perneczky; Oren Tene; Johannes Attems; Panteleimon Giannakopoulos; M Arfan Ikram; Antonio Federico; Marie Sarazin; Lefkos T Middleton Journal: BMC Med Date: 2016-11-03 Impact factor: 8.775
Authors: Iain D Croall; Valerie Lohner; Barry Moynihan; Usman Khan; Ahamad Hassan; John T O'Brien; Robin G Morris; Daniel J Tozer; Victoria C Cambridge; Kirsty Harkness; David J Werring; Andrew M Blamire; Gary A Ford; Thomas R Barrick; Hugh S Markus Journal: Clin Sci (Lond) Date: 2017-06-07 Impact factor: 6.124